• Sign In
  • Sign Up
  • Sign In
  • Sign Up
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
ADA 85th Scientific Sessions ’25

The Relationship of Relative Fat Mass (RFM) to In Vivo Peripheral, Hepatic, and Adipose Insulin Sensitivity (IS) and Cardiometabolic Risk Factors in Youth across the Adiposity Spectrum

This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity” on June 22nd, 2025, at

Read More »
August 22, 2025
ADA 85th Scientific Sessions ’25

CagriSema Demonstrates Dual Benefit in Obesity and Type 2 Diabetes

This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at the 85th ADA Scientific Sessions

Read More »
August 20, 2025
ADA 85th Scientific Sessions ’25

Higher Static Phase Insulin Secretory Rate Compensates for Lower Insulin Sensitivity in South Asian Youth—The Charisma Study

This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity” on June 22nd, 2025, at

Read More »
August 14, 2025
ADA 85th Scientific Sessions ’25

STRIDE: Semaglutide Reduces Progression of PAD by 54% in Type 2 Diabetes

This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at the 85th ADA Scientific Sessions

Read More »
August 12, 2025
ADA 85th Scientific Sessions ’25

The Broader Impact of Sotagliflozin–Metaanalysis of Its Efficacy in Diabetes Management, Cardiovascular Risk Reduction, and Renal Outcome

This paper was presented as a part of the session “Dropping Cost and Complications—CVD Risk and DM—SGLT2s and GLPs for CVD” on June 22nd, 2025,

Read More »
August 11, 2025
ADA 85th Scientific Sessions ’25

Association between Triglyceride, Glucose, and Body Mass Index and Long-Term Adverse Outcomes in Heart Failure Patients with Coronary Heart Disease

This paper was presented as a part of the session “The Tidal Wave Is Coming—Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2

Read More »
August 8, 2025
ADA 85th Scientific Sessions ’25

Comparative Evaluation of Current Therapeutic Agents for Heart Failure with Preserved Ejection Fraction (HFpEF)–A Systematic Review and Network Meta-analysis

This paper was presented as a part of the session “The Tidal Wave Is Coming—Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2

Read More »
August 7, 2025
ADA 85th Scientific Sessions ’25

Diabetes and Peripheral Artery Disease— Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial

This session was presented on June 21st, 2025, at the 85th ADA Scientific Sessions being held in Chicago, IL. A major international clinical trial has

Read More »
August 6, 2025
ADA 85th Scientific Sessions ’25

Time in Range (TIR) Extrapolated from Self- Monitoring of Blood Glucose (SMBG) and Risk for Adverse Perinatal Outcomes in Pregnancies Complicated by T1DM

This paper was presented as a part of the session “New Approaches to Detect and Monitor Diabetes in Pregnancy?” on June 21st, 2025, at the

Read More »
August 5, 2025
ADA 85th Scientific Sessions ’25

Hyperglycemia Threshold Associated with Adverse Pregnancy Outcomes in Gestational Diabetes Mellitus

This paper was presented as a part of the session “New Approaches to Detect and Monitor Diabetes in Pregnancy?” on June 21st, 2025, at the

Read More »
August 1, 2025
Page1 Page2 Page3 Page4 Page5
Latest Conferences
  • Insulin Clearance Tracks Rapid Disease Progression in Preclinical T1D
  • Glucose, Not Insulin, Appears to Be the Main Regulator of Glucagon Secretion in Healthy Individuals
  • Semaglutide and Obstructive Sleep Apnea, SELECT Post-Hoc Analysis
  • Metformin Randomization Associated with Prevalent Cognitive Impairment in DPP Outcomes Study
  • Semaglutide Reduces COVID-19 Complications and All-Cause Death, SELECT + FLOW + SOUL Pooled
Societies
  • ACC: American College of Cardiology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • BAD: British Association of Dermatologists
  • ERA EDTA: European Renal Association – European Dialysis and Transplant Association
  • ESC: European Society of Cardiology
  • ISN: International Society of Nephrology
  • WCPD: World Congress of Pediatric Dermatology
  • AHA: American Heart Association
  • AAD: American Association of Dermatology
  • AACE: American Association of Clinical Endocrinology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • ISN: International Society of Nephrology
  • IASP: International Association for the Study of Pain
  • SCAI: Society for Cardiovascular Angiography and Interventions
  • AAO-HNS: American Academy of Otolaryngology–Head and Neck Surgery
Speciality
  • Cardiology
  • Endocrinology
  • Nephrology
  • Neurology
  • Dermatology
  • Obstetrics & Gynecology
  • Pain
  • Respiratory
  • Otolaryngology
Tags
AACE ACC ADA AHA ASN BAD ERA ESC ISN ISN-WCN 2021 Kidney Week 2020 SCAI WCPD wcpn

© All rights reserved.